{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:30:41Z","timestamp":1772119841349,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR19-CE17-0027"],"award-info":[{"award-number":["ANR19-CE17-0027"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11307-023-01864-z","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:01:41Z","timestamp":1696590101000},"page":"1135-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Parametric Imaging of P-Glycoprotein Function at the Blood\u2013Brain Barrier Using kE,brain-maps Generated from [11C]Metoclopramide PET Data in Rats, Nonhuman Primates and Humans"],"prefix":"10.1007","volume":"25","author":[{"given":"Louise","family":"Breuil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"El Biali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Vodovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Auvity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Goutal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-2030","authenticated-orcid":false,"given":"Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"1864_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AAK, Dolman DEM et al (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.030","journal-title":"Neurobiol Dis"},{"key":"1864_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/clpt.2009.138","volume":"86","author":"P Kannan","year":"2009","unstructured":"Kannan P, John C, Zoghbi SS et al (2009) Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin Pharmacol Ther 86:368\u2013377. https:\/\/doi.org\/10.1038\/clpt.2009.138","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 7","key":"1864_CR3","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1002\/jcph.722","volume":"56","author":"O Langer","year":"2016","unstructured":"Langer O (2016) Use of PET imaging to evaluate transporter-mediated drug-drug interactions. J Clin Pharmacol 56(Suppl 7):S143-156. https:\/\/doi.org\/10.1002\/jcph.722","journal-title":"J Clin Pharmacol"},{"key":"1864_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","volume":"55","author":"AK Deo","year":"2014","unstructured":"Deo AK, Borson S, Link JM et al (2014) Activity of P-glycoprotein, a \u03b2-amyloid transporter at the blood-brain barrier, is compromised in patients with mild Alzheimer\u2019s disease. J Nucl Med 55:1106\u20131111. https:\/\/doi.org\/10.2967\/jnumed.113.130161","journal-title":"J Nucl Med"},{"key":"1864_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JCH et al (2005) Blood\u2013brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57:176\u2013179. https:\/\/doi.org\/10.1002\/ana.20369","journal-title":"Ann Neurol"},{"key":"1864_CR6","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.2174\/1381612822666160804093852","volume":"22","author":"M Lubberink","year":"2016","unstructured":"Lubberink M (2016) Kinetic models for measuring P-glycoprotein function at the blood-brain barrier with positron emission tomography. Curr Pharm Des 22:5786\u20135792. https:\/\/doi.org\/10.2174\/1381612822666160804093852","journal-title":"Curr Pharm Des"},{"key":"1864_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pharmthera.2018.04.006","volume":"189","author":"N Tournier","year":"2018","unstructured":"Tournier N, Stieger B, Langer O (2018) Imaging techniques to study drug transporter function in vivo. Pharmacol Ther 189:104\u2013122. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.04.006","journal-title":"Pharmacol Ther"},{"key":"1864_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2967\/jnumed.108.059162","volume":"50","author":"M Muzi","year":"2009","unstructured":"Muzi M, Mankoff DA, Link JM et al (2009) Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans. J Nucl Med 50:1267\u20131275. https:\/\/doi.org\/10.2967\/jnumed.108.059162","journal-title":"J Nucl Med"},{"key":"1864_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/clpt.2011.217","volume":"91","author":"M Bauer","year":"2012","unstructured":"Bauer M, Zeitlinger M, Karch R et al (2012) P-glycoprotein mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier studied with positron emission tomography, a comparison with rat data. Clin Pharmacol Ther 91:227\u2013233. https:\/\/doi.org\/10.1038\/clpt.2011.217","journal-title":"Clin Pharmacol Ther"},{"key":"1864_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2967\/jnumed.109.070151","volume":"51","author":"WC Kreisl","year":"2010","unstructured":"Kreisl WC, Liow J-S, Kimura N et al (2010) P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide. J Nucl Med 51:559\u2013566. https:\/\/doi.org\/10.2967\/jnumed.109.070151","journal-title":"J Nucl Med"},{"key":"1864_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2967\/jnumed.118.219972","volume":"60","author":"N Tournier","year":"2019","unstructured":"Tournier N, Bauer M, Pichler V et al (2019) Impact of P-glycoprotein function on the brain kinetics of the weak substrate 11C-metoclopramide assessed with PET imaging in humans. J Nucl Med 60:985\u2013991. https:\/\/doi.org\/10.2967\/jnumed.118.219972","journal-title":"J Nucl Med"},{"key":"1864_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2967\/jnumed.119.237198","volume":"61","author":"V Zoufal","year":"2020","unstructured":"Zoufal V, Mairinger S, Brackhan M et al (2020) Imaging P-glycoprotein induction at the blood-brain barrier of a \u03b2-amyloidosis mouse model with 11C-metoclopramide PET. J Nucl Med 61:1050\u20131057. https:\/\/doi.org\/10.2967\/jnumed.119.237198","journal-title":"J Nucl Med"},{"key":"1864_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2967\/jnumed.115.164350","volume":"57","author":"G Pottier","year":"2016","unstructured":"Pottier G, Marie S, Goutal S et al (2016) Imaging the impact of the P-glycoprotein (ABCB1) function on the brain kinetics of metoclopramide. J Nucl Med 57:309\u2013314. https:\/\/doi.org\/10.2967\/jnumed.115.164350","journal-title":"J Nucl Med"},{"key":"1864_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533\u20131539. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600493","journal-title":"J Cereb Blood Flow Metab"},{"key":"1864_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2967\/jnumed.118.210104","volume":"59","author":"S Auvity","year":"2018","unstructured":"Auvity S, Caill\u00e9 F, Marie S et al (2018) P-Glycoprotein (ABCB1) inhibits the influx and increases the efflux of 11C-metoclopramide across the blood-brain barrier: a PET study on nonhuman primates. J Nucl Med 59:1609\u20131615. https:\/\/doi.org\/10.2967\/jnumed.118.210104","journal-title":"J Nucl Med"},{"key":"1864_CR16","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.3390\/pharmaceutics14122650","volume":"14","author":"L Breuil","year":"2022","unstructured":"Breuil L, Ziani N, Leterrier S et al (2022) Impact of cytochrome induction or inhibition on the plasma and brain kinetics of [11C]metoclopramide, a PET probe for p-glycoprotein function at the blood-brain barrier. Pharmaceutics 14:2650. https:\/\/doi.org\/10.3390\/pharmaceutics14122650","journal-title":"Pharmaceutics"},{"key":"1864_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/0271678X211045444","volume":"42","author":"L Breuil","year":"2022","unstructured":"Breuil L, Marie S, Goutal S et al (2022) Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: a criterion of choice? J Cereb Blood Flow Metab 42:175\u2013185. https:\/\/doi.org\/10.1177\/0271678X211045444","journal-title":"J Cereb Blood Flow Metab"},{"key":"1864_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/jcbfm.2015.19","volume":"35","author":"M Bauer","year":"2015","unstructured":"Bauer M, Karch R, Zeitlinger M et al (2015) Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study. J Cereb Blood Flow Metab 35:743\u2013746. https:\/\/doi.org\/10.1038\/jcbfm.2015.19","journal-title":"J Cereb Blood Flow Metab"},{"key":"1864_CR19","first-page":"1179","volume":"39","author":"J Taki","year":"1998","unstructured":"Taki J, Sumiya H, Asada N et al (1998) Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. J Nucl Med 39:1179\u20131184","journal-title":"J Nucl Med"},{"key":"1864_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S1474-4422(13)70109-1","volume":"12","author":"M Feldmann","year":"2013","unstructured":"Feldmann M, Asselin M-C, Liu J et al (2013) P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet Neurol 12:777\u2013785. https:\/\/doi.org\/10.1016\/S1474-4422(13)70109-1","journal-title":"Lancet Neurol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01864-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01864-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01864-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T13:10:15Z","timestamp":1702905015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01864-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1864"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01864-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2920574\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}